|
1
|
Chuang SC, Hashibe M, Scelo G, Brewster
DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro
S, et al: Risk of second primary cancer among esophageal cancer
patients: A pooled analysis of 13 cancer registries. Cancer
Epidemiol Biomarkers Prev. 17:1543–1549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reddy Lakshminarayana CN, Vyjayanti VN,
Notani D, Galande S and Kotamraju S: Down-regulation of the global
regulator SATB1 by statins in COLO205 colon cancer cells. Mol Med
Rep. 3:857–861. 2010.PubMed/NCBI
|
|
3
|
Ordinario E, Han HJ, Furuta S, Heiser LM,
Jakkula LR, Rodier F, Spellman PT, Campisi J, Gray JW, Bissell MJ,
et al: ATM suppresses SATB1-induced malignant progression in breast
epithelial cells. PLoS One. 7:e517862012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Sohaily S, Henderson C, Selinger C,
Pangon L, Segelov E, Kohonen-Corish MR and Warusavitarne J: Loss of
special AT-rich sequence-binding protein 1 (SATB1) predicts poor
survival in patients with colorectal cancer. Histopathology.
65:155–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakayama Y, Mian IS, Kohwi-Shigematsu T
and Ogawa T: A nuclear targeting determinant for SATB1, a genome
organizer in the T cell lineage. Cell Cycle. 4:1099–1106. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cai S, Han HJ and Kohwi-Shigematsu T:
Tissue-specific nuclear architecture and gene expression regulated
by SATB1. Nat Genet. 34:42–51. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frömberg A, Rabe M and Aigner A: Multiple
effects of the special AT-rich binding protein 1 (SATB1) in colon
carcinoma. Int J Cancer. 135:2537–2546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Gu X, Zhang G, Wang L, Wang T,
Zhao Y, Zhang X, Zhou Y, Kadin M and Tu P: SATB1 overexpression
promotes malignant T-cell proliferation in cutaneous CD30+
lymphoproliferative disease by repressing p21. Blood.
123:3452–3461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grzanka J, Leveson-Gower D, Golab K, Wang
XJ, Marek-Trzonkowska N, Krzystyniak A, Wardowska A, Mills JM,
Trzonkowski P and Witkowski P: FoxP3, Helios, and SATB1: Roles and
relationships in regulatory T cells. Int Immunopharmacol.
16:343–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kobierzycki C, Wojnar A and Dziegiel P:
Expression of SATB1 protein in the ductal breast carcinoma tissue
microarrays-preliminary study. Folia Histochem Cytobiol.
51:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim CJ, Lee GR, Shin JW, Jung SW, Park BR
and Park NH: Mutational analysis of SATB1 gene in hepatocellular
carcinomas. APMIS. 121:1012–1014. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tracz AF, Peczek Ł, Zuk K, Stec-Michalska
K and Nawrot B: Effect of Helicobacter pylori eradication on the
expression level of SATB1 and c-Myc genes in gastric mucosa of
patients with family history of gastric cancer. Pol Merkur
Lekarski. 34:269–276. 2013.(In Polish). PubMed/NCBI
|
|
13
|
Kohwi-Shigematsu T, Poterlowicz K,
Ordinario E, Han HJ, Botchkarev VA and Kohwi Y: Genome organizing
function of SATB1 in tumor progression. Semin Cancer Biol.
23:72–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang HZ, Jin GF and Shen HB:
Epidemiologic differences in esophageal cancer between Asian and
Western populations. Chin J Cancer. 31:281–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng S, Vuitton L, Sheyhidin I, Vuitton
DA, Zhang Y and Lu X: Northwestern China: A place to learn more on
oesophageal cancer. Part one: Behavioural and environmental risk
factors. Eur J Gastroenterol Hepatol. 22:917–925. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferri F: ‘Esophageal Tumors’Ferri's
clinical advisor 2013. Philadelphia, PA: Mosby (Elsevier); pp.
389–391. 2012
|
|
17
|
Hanna A, Birla R, Iosif C, Boeriu M, Tomsa
R, Puscasu A and Constantinoiu S: Evaluation of neoadjuvant
radiochemotherapy response (RCT) in squamous esophageal cancer
(ESC) and implications in therapeutic conduct. Chirurgia (Bucur).
110:214–223. 2015.PubMed/NCBI
|
|
18
|
Berry MF: Esophageal cancer: Staging
system and guidelines for staging and treatment. J Thorac Dis.
6:(Suppl 3). S289–S297. 2014.PubMed/NCBI
|
|
19
|
Soni B, el Hassan B and Mahmoud B:
Chemical isolation and characterization of different cellulose
nanofibers from cotton stalks. Carbohydr Polym. 134:581–589. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kumar Pavan P, Purbey PK, Sinha CK, Notani
D, Limaye A, Jayani RS and Galande S: Phosphorylation of SATB1, a
global gene regulator, acts as a molecular switch regulating its
transcriptional activity in vivo. Mol Cell. 22:231–243. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsu SM and Jaffe ES: Phenotypic expression
of B-lymphocytes. 1. Identification with monoclonal antibodies in
normal lymphoid tissues. Am J Pathol. 114:387–395. 1984.PubMed/NCBI
|
|
22
|
Gudat FG, Forster HK, Suter F, Albrecht R,
Krey G, Dürmüller U, Girard MF and Obrecht JP: Tissue distribution
and ultrastructure of B lymphocytes reacting with the monoclonal
antibody anti-Y29/55. Virchows Arch B Cell Pathol Incl Mol Pathol.
48:341–350. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han HJ, Russo J, Kohwi Y and
Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote
breast tumour growth and metastasis. Nature. 452:187–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng Z, Wang C, Fang E, Lu X, Wang G and
Tong Q: Co-delivery of doxorubicin and SATB1 shRNA by
thermosensitive magnetic cationic liposomes for gastric cancer
therapy. PLoS One. 9:e929242014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fang XF, Hou ZB, Dai XZ, Chen C, Ge J,
Shen H, Li XF, Yu LK and Yuan Y: Special AT-rich sequence-binding
protein 1 promotes cell growth and metastasis in colorectal cancer.
World J Gastroenterol. 19:2331–2339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang B, Zhou H, Wang X and Liu Z:
Silencing SATB1 with siRNA inhibits the proliferation and invasion
of small cell lung cancer cells. Cancer Cell Int. 13:82013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou L, Yu L, Zhu B, Wu S, Song W, Gong X
and Wang D: Metastasis-associated in colon cancer-1 and aldehyde
dehydrogenase 1 are metastatic and prognostic biomarker for
non-small cell lung cancer. BMC Cancer. 16:8762016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiang J, Zhou L, Li S, Xi X, Zhang J, Wang
Y, Yang Y, Liu X and Wan X: AT-rich sequence binding protein 1:
Contribution to tumor progression and metastasis of human ovarian
carcinoma. Oncol Lett. 3:865–870. 2012.PubMed/NCBI
|
|
29
|
Zheng J: Is SATB1 a master regulator in
breast cancer growth and metastasis? Womens Health (Lond).
4:329–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
